908 Devices Q3 revenue $12.5M (+107% YoY), net loss $5.2M; narrows FY guidance to $41-43M

908 Devices Inc.

2021-Q3 EPS reported -$0.68 revenue$26,365,000

Q3 revenue $12.5M, up 52% sequentially and 107% YoY; net loss $5.2M ($0.19 loss per share).
Product/service gross margin 54% vs 64% a year ago; operating expenses rose to $12.1M from $5.1M.
Installed base reached 1,714 devices with 184 placements in Q3, driven by handheld adoption.
Full year 2021 revenue guidance raised low end to $41-43M from $40-43M, growth 52-60%.
Cash $139M; $15M debt; launched ZipChip Oligonucleotides kit, partnered with Ohio AG for counterfeit drug detection.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.